Skip to main content
Back to OrbiMed

OrbiMed's Biotechnology Portfolio

Browse 172 Biotechnology companies funded by OrbiMed. See funding amounts, founder contacts, and investment details.

Biotechnology Companies
172
Total Funding in Biotechnology
$19.9B

Biotechnology Portfolio Companies (172)

Export
BiopharmaBiotechnologyGeneticsMedicalPharmaceuticalTherapeutics

ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics.

Dallas, United States
September 2025
$29.4M
Debt Financing

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Synlogic is a biotechnology company that develops synthetic biotic medicines to perform metabolic functions to treat diseases.

Cambridge, United States
September 2023
$21.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth Care

ACELYRIN is a biopharma company that identifies, acquires, and accelerates the development and commercialization of life-changing therapies.

Los Angeles, United States
September 2022
$300.0M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife ScienceOncology

XinThera is a drug discovery company focused on building small molecule oncology and immunology pipeline.

San Diego, United States
August 2021
$50.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsPharmaceutical

A private biopharmaceutical company .

Woburn, United States
August 2021
$60.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceutical

ScPharmaceuticals is a biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery.

Lexington, United States
August 2024
$125.0M
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

BiotechnologyLife Science

GentiBio is a biotherapeutics company developing engineered regulatory T cells programmed to treat autoimmune allergic diseases.

Seattle, United States
August 2021
$157.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsMedicalOncology

Fore Biotherapeutics is a precision oncology company specializing in cancer therapies guided by functional genomics.

Philadelphia, United States
July 2026
$67.4M
Series D

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedical

NeRRe Therapeutics is a biotechnology company that develops clinical and pre-clinical neurokinin receptor antagonists.

Stevenage, United Kingdom
July 2021
$27.6M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeuticsWellness

Achilles Therapeutics is a developer of immunotherapies intended to offer next-generation, patient-specific therapies to treat cancer.

London, United Kingdom
July 2022
$4.1M
Grant

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CareHealth DiagnosticsMedical

DELFI's AI platform uses whole-genome sequencing to detect cancer-associated cfDNA fragmentation patterns in the blood.

Palo Alto, United States
July 2022
$225.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife ScienceOncologyPrecision Medicine

Scorpion Therapeutics is a clinical-stage oncology company that specializes in precision medicine for cancer patients.

Boston, United States
July 2024
$150.0M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Asceneuron develops effective therapeutics for orphan tauopathies and Alzheimer’s disease.

Lausanne, Switzerland
July 2024
$100.0M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.

Cambridge, United States
July 2026
$200.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyGeneticsHealth CareTherapeutics

Imara is provider of novel therapeutics for the people living with sickle cell disease and hemoglobinopathies.

Cambridge, United States
July 2021
$50.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyInnovation ManagementTherapeutics

Turnstone Biologics is a privately-held clinical stage biotech company.

La Jolla, United States
July 2021
$80.0M
Series D

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceOncologyPharmaceutical

Erasca is a developer of oncology drugs intended to provide precision oncology options.

San Diego, United States
July 2026
$632.5M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Renasant Bio is a biopharmaceutical company pioneering disease-modifying oral small molecule treatments.

Berkeley, United States
July 2025
$54.5M
Seed

Founder Contacts

41,000+ verified contacts

BiotechnologyPharmaceuticalTherapeutics

Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics

Boston, United States
July 2025
$175.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

Upstream Bio focuses on developing an antibody therapy for the treatment of severe asthma.

Waltham, United States
June 2023
$200.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyLife Science

MiroBio is Harnessing the natural control mechanisms of the immune system.

Oxford, United Kingdom
June 2022
$97.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife ScienceNeuroscienceTherapeutics

Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.

Cambridge, United States
June 2024
$40.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Nuvation Bio is a global biopharmaceutical company focusing on unmet needs in oncology.

New York, United States
June 2026
$250.0M
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

BiotechnologyInformation TechnologyManufacturingMedicalTechnical Support

Averna Therapeutics develops genomic therapeutics that introduce therapeutic genes into safe shelters within the DNA.

Boston, United States
June 2024
$85.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMental HealthNeurosciencePharmaceutical

Helus Pharma is a biopharmaceutical company that develops psychedelic therapeutics for mental health conditions.

Toronto, Canada
June 2026
$50.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Biotechnology

Frontera Therapeutics is an AAV gene therapy company that focuses on rAAV therapies for the global market.

Bedford, United States
June 2022
$160.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Aeglea BioTherapeutics is a clinical-stage biotechnology company that develops enzyme therapies for rare metabolic diseases.

Austin, United States
June 2023
$210.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Triveni Bio is a biotechnology company that develops antibody-based therapeutics for immunological and inflammatory diseases.

Watertown, United States
June 2026
$65.0M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceOncologyTherapeutics

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.

Boulder, United States
June 2026
$460.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyLife Science

Shattuck Labs is a biotechnology company that provides novel class biologic medicines for the treatment of cancer and autoimmune disease.

Austin, United States
June 2026
$75.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyPharmaceuticalTherapeutics

Sirius Therapeutics is an innovative biotechnology company that focuses on RNAi therapies for cardiovascular diseases.

San Diego, United States
May 2025
$50.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyTherapeutics

Avalo Therapeutics is a clinical-stage biopharmaceutical company.

Rockville, United States
May 2026
$431.3M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceMedicalTherapeutics

Apogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders.

San Francisco, United States
May 2026
$1.3B
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Chinook Therapeutics is a biotechnology company that specializes in the fields of therapeutics and life science.

Vancouver, Canada
May 2022
$105.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsOncologyTherapeutics

Ikena Oncology develops differentiated therapies to target cancer growth and resistance, focusing on Hippo and RAS signaling pathways.

Boston, United States
May 2023
$40.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyLife ScienceOncology

Whitehawk Therapeutics, a clinical-stage oncology therapeutics firm, applies cutting-edge technologies to well-established tumor biology.

Pacific Palisades, United States
May 2026
$87.5M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Sidewinder Therapeutics is a biotechnology company that offers life-saving therapies for cancer and rare diseases.

San Diego, United States
April 2026
$137.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife SciencePharmaceutical

Forte Biosciences is a biotechnology company that focuses on dermatology.

Sherman Oaks, United States
April 2026
$150.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyGeneticsHealth CareMedicalTherapeutics

Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments.

Cambridge, United States
April 2026
$180.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsManufacturingMedical Device

Acutus Medical develops medical technologies to treat complex cardiac arrhythmia.

Carlsbad, United States
April 2022
$35.0M
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsMedical

Adela creates develops technologies centered around detecting high-risk conditions like cancer through routine blood tests.

Foster City, United States
April 2026
$5.0M
Convertible Note

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyPharmaceuticalTherapeutics

Prelude Therapeutics designs and develops small molecule therapies targeting key drivers of cancer cell growth and resistance.

Wilmington, United States
April 2026
$90.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyMedical DeviceOncology

Cullinan Therapeutics is a developer of an externally sourced cancer therapeutics used to end a drug program quickly.

Cambridge, United States
April 2024
$280.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Biotechnology

Terremoto Biosciences is a biotechnology company leveraging the power of lysine-based covalency to develop optimized medicines.

San Francisco, United States
April 2026
$108.0M
Series C

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth Care

ImageneBio is dedicated to developing therapeutics for patients with immunological, autoimmune and inflammatory diseases

San Diego, United States
April 2026
$30.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyGeneticsHealth CareMedicalPharmaceuticalTherapeutics

Sionna Therapeutics is developing novel small molecule therapies to treat cystic fibrosis (CF).

Natick, United States
March 2024
$182.0M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareOncologyPharmaceutical

Apollomics is a biopharmaceutical company discovering and developing mono- and combination- oncology therapies to harness the immune system.

Foster City, United States
March 2026
$2.0M
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedical

Lomond Therapeutics creates pharmacological platforms that target escape mutations.

San Diego, United States
March 2025
$20.0M
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyMedicalTherapeutics

Pinnacle Medicines is a peptide drug discovery company that provides peptide modality for medical needs.

Doylestown, United States
March 2026
$89.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth Care

Nkarta Therapeutics is a developer of cell engineering platform created to build the next generation of cell therapies.

South San Francisco, United States
March 2024
$240.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Capstan Therapeutics develops in vivo mRNA and gene-editing medicines for a broad range of diseases.

San Diego, United States
March 2024
$175.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyMedical

Congruence Therapeutics operates as a biotechnology company.

Montréal, Canada
March 2026
$39.5M
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedical

Curevo is a clinical-stage biotechnology company developing next-generation, non-mRNA vaccines for infectious diseases.

Bothell, United States
March 2025
$110.0M
Series B

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyClinical TrialsMedicalPharmaceutical

Harvest Integrated Research Organization (HiRO) is a globally oriented, innovative clinical research organization (CRO).

Excelsior, United States
March 2022
$1.6M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyMedicalTherapeutics

Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer.

Los Angeles, United States
March 2022
$10.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyPharmaceuticalTherapeutics

QuantX Biosciences is a biotechnology company that specializes in computational drug discovery and small-molecule therapeutic products.

Princeton, United States
February 2026
$85.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyLife Science

ImmPACT Bio USA is developing novel cell therapies for treating cancer.

Camarillo, United States
February 2024
$8.0M
Grant

Founder Contacts

41,000+ verified contacts

BiotechnologyNutritionSoftware

Cyrus Biotechnology is a developer of Rosetta software platform that solves drug discovery problems.

Seattle, United States
February 2024
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceOncologyTherapeutics

Tyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs.

Carlsbad, United States
February 2024
$200.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyMedicalOncologyPharmaceutical

Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing radiopharmaceuticals.

Hamilton, Canada
February 2023
$60.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth CareOncologyTherapeutics

Xilio Therapeutics is a biotechnology company that develops tumor-activated immuno-oncology therapies.

Waltham, United States
February 2026
$40.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyPharmaceuticalTherapeutics

Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.

Portland, United States
September 2025
$95.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedicalOncologyTherapeutics

Avenzo Therapeutics specializes in the development of oncology therapies for cancer treatment.

San Diego, United States
September 2025
$60.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedicalPrecision Medicine

Treeline Biosciences is a biotech company building transformative precision medicines for patients with cancer and other serious conditions.

Watertown, United States
September 2025
$200.0M
Series A

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyMedical

ENYO Pharma is a biopharmaceutical company based in Lyon, France.

Lyon, France
June 2025
$6.9M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsMedical

Alpheus Medical provides a novel sonodynamic therapy platform targeting solid body cancers.

Oakdale, United States
May 2025
$52.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyMedical

RayThera is dedicated to developing small molecule therapies specifically targeting unmet needs in immunology.

San Diego, United States
April 2025
$110.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife ScienceTherapeutics

Garuda Therapeutics develops off-the-shelf hematopoietic stem cell therapies to treat severe and life-threatening diseases.

Cambridge, United States
March 2025
$50.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Aer Therapeutics, a clinical-stage biopharmaceutical company developing therapeutic solutions for muco-obstructive lung diseases.

Raleigh, United States
February 2025
$5.0M
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedicalTherapeutics

Helicore Biopharma is a biopharmaceutical company that discovers and develops novel weight-loss therapeutics.

San Mateo, United States
January 2025
$65.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeutics

MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.

Carmel, United States
August 2024
$63.5M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedical

Vanqua Bio is a biotechnology company that discovers and develops next-generation medicines for patients with neurodegenerative diseases.

Chicago, United States
July 2024
$45.0M
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

Alterome Therapeutics is a biopharmaceutical company developing alteration-specific targeted therapies.

San Diego, United States
April 2024
$132.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyOncologyTherapeutics

ProfoundBio is a developer of targeted therapeutics intended for patients with cancer.

Seattle, United States
February 2024
$112.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareOncologyPharmaceuticalProduct Research

OnCusp Therapeutics is a biopharmaceutical company turning cutting-edge research assets into innovative oncology treatments.

New York, United States
January 2024
$100.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareInternetPharmaceutical

Koya Medical is a transformative healthcare company developing breakthrough treatments for lymphedema and venous diseases.

Oakland, United States
November 2023
$30.0M
Series C

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyMedicalTherapeutics

Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases.

La Jolla, United States
October 2023
$85.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedicalWellness

Minervax is a biotechnology company developing a novel vaccine against Group B Streptococcus.

Hellerup, Denmark
October 2023
$57.4M
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyLife ScienceMedicalTherapeutics

Evozyne is a generative AI company that focuses on therapeutic discovery and drug development.

Chicago, United States
September 2023
$81.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyPharmaceuticalTherapeutics

Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations.

Paris, France
September 2023
$69.5M
Series A

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyLife Science

CHARM Therapeutics uses deep learning on 3D molecular configurations to develop molecule therapeutics to target pathogenic proteins.

London, United Kingdom
April 2023
$20.0M
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeutics

AirNexis Therapeutics develops clinical-stage therapies for chronic obstructive pulmonary disease and other pulmonary conditions.

Palo Alto, United States
January 2026
$200.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedical

Verdiva Bio creates cutting-edge treatments that improve results for patients with obesity and cardiometabolic diseases.

London, United Kingdom
January 2025
$411.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareHealth Diagnostics

Century Therapeutics is a biotechnology company that develops cell therapies for hematological and solid tumor malignancies.

Philadelphia, United States
January 2026
$135.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife ScienceNeurosciencePharmaceuticalTherapeutics

Aviceda Therapeutics is a late-stage pre-clinical biotech company developing drugs for treating glyco-immune diseases.

Cambridge, United States
January 2025
$207.5M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceuticalWellness

Amolyt Pharma specializes in peptides for the treatment of rare endocrine and metabolic disorders.

Écully, France
January 2023
$138.6M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.

Lexington, United States
January 2024
$140.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedicalMedical DevicePharmaceutical

Terns Pharmaceuticals develops small-molecule therapies for chronic diseases including cancer, metabolic disorders, and liver conditions.

Foster City, United States
December 2025
$650.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

89bio is a biopharmaceutical company that develops clinical-stage therapies for liver and cardiometabolic diseases.

San Francisco, United States
January 2025
$287.5M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyFitnessHealth CareWellness

Emergence is a biopharmaceutical company working on novel ADC immunotherapies for cancers with a high unmet need.

Duisburg, Germany
December 2021
$98.1M
Series A

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyTherapeutics

SpringWorks Therapeutics is a biopharmaceutical company that develops medicines for patients with severe rare diseases and cancer.

Stamford, United States
December 2023
$275.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth DiagnosticsPharmaceuticalTherapeutics

Janux Therapeutics develops immunotherapies that generates immune responses to prevent tumors and not affecting a patient’s healthy tissue.

La Jolla, United States
December 2024
$350.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyData Collection and LabelingHealth CareMedical DeviceWearables

Biobeat is a med-tech company that develops remote patient monitoring and data collection tool.

Boca Raton, United States
December 2025
$50.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife Science

Third Harmonic Bio is a clinical-stage company developing a first-in-class, highly selective, and oral kit inhibitor.

Cambridge, United States
January 2025
$3.9M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedical

Gennao Bio is a genetic medicines company that develops targeted nucleic acid therapeutics to cure muscle diseases.

New York, United States
December 2021
$1.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Ottimo Pharma develops innovative cancer therapies using PD1-VEGFR2 antibodies.

Sandwich, United Kingdom
December 2024
$140.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth DiagnosticsMedicalTherapeutics

SiteOne Therapeutics develops groundbreaking non-opioid treatments for acute, neuropathic, visceral, and musculoskeletal pain.

South San Francisco, United States
December 2024
$100.0M
Series C

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.

Burlingame, United States
January 2026
$201.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareManufacturingTherapeutics

ProLynx is a biotechnology company that develops proprietary drug-delivery technologies to extend the half-life of therapeutic molecules.

San Francisco, United States
December 2025
$70.0M
Series A

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth CareOncologyPharmaceuticalTherapeutics

BlossomHill Therapeutics is a biopharmaceutical company focusing on oncology and autoimmune disorders.

San Diego, United States
December 2025
$84.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedical

Alpine Immune Sciences is an immunotherapy company focused on developing treatments for autoimmune and inflammatory diseases.

Seattle, United States
November 2023
$150.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Braveheart Bio is a clinical-stage biotechnology company focused on developing precision therapies in the cardiovascular disease space.

San Francisco, United States
November 2025
$185.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedical DeviceTherapeutics

Aerin Medical is a health technology company that develops therapeutic devices to improve nasal breathing.

Mountain View, United States
January 2025
$32.5M
Undisclosed

Founder Contacts

41,000+ verified contacts

BiotechnologyGenetics

iECURE is a mutation-agnostic in vivo gene editing company striving to cure devastating diseases with high unmet needs.

Philadelphia, United States
November 2022
$65.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsMedical

PierianDx is catalyzing global adoption of genomic sequencing in healthcare

St Louis, United States
November 2021
$30.0M
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

BiotechnologyMedicalNeurosciencePharmaceuticalTherapeutics

Aspen Neuroscience is a biotechnology company that specializes in personalized cell therapies and autologous regenerative medicine.

San Diego, United States
November 2025
$115.0M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyPharmaceuticalTherapeutics

Invivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections.

Waltham, United States
November 2025
$125.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

Verastem is a biopharmaceutical company developing new medicines to improve the lives of patients with RAS/MAPK pathway-driven cancers.

Needham, United States
November 2025
$90.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyLife SciencePharmaceutical

TELA Bio is a life science company that specializes in soft tissue reconstruction.

Malvern, United States
November 2025
$60.0M
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedicalTherapeutics

Adicet Bio is a biotechnology company discovering and developing first-in-class allogeneic gamma delta CAR t cell therapies for cancer

Redwood City, United States
October 2025
$80.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth Care

Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.

Plymouth Meeting, United States
October 2024
$248.0M
Post-IPO Secondary

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareOncologyPharmaceuticalTherapeutics

Repare Therapeutics is a developer of oncology drugs designed to target specific vulnerabilities of tumor cells.

Saint Laurent, Canada
October 2021
$101.2M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyClinical TrialsHealth CareOncologyPharmaceuticalTherapeutics

X4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment.

Cambridge, United States
October 2025
$155.3M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Harpoon Therapeutics is a clinical-stage immunotherapy company focused on the development of novel T-cell recruiting biologic therapies.

South San Francisco, United States
October 2023
$100.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

PIC Therapeutics is a biotechnology company focused on transforming the treatment of cancer.

Natick, United States
October 2022
$35.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyGeneticsTherapeuticsVeterinary

Scout Bi is a biotechnology company that specializes in veterinary, animal health, and gene therapy.

Philadelphia, United States
October 2021
$33.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedical

VectivBio is a biotechnology company committed to making innovative treatments for patients suffering from serious rare diseases.

Basel, Switzerland
October 2022
$125.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeutics

BIOMx is a microbiome therapeutics company developing synbio phage therapies to eradicate harmful bacteria in chronic diseases.

Ness Ziona, Israel
December 2025
$3.0M
Post Ipo Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceMedicalTherapeutics

Proviva Therapeutics is a pro-drug design platform for cytokines and other fusion proteins.

Shanghai, China
December 2025
$30.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyMedical

TandemAI is an advanced technology company dedicated to reinventing drug discovery infrastructure.

Shanghai, China
November 2025
$22.0M
Series A

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth CareOncology

NextCure is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs.

Beltsville, United States
November 2025
$21.5M
Post Ipo Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Valneva focuses on the development and commercialization of prophylactic vaccines for infectious diseases.

Saint-herblain, France
October 2025
$215.0M
Post Ipo Debt

Founder Contacts

41,000+ verified contacts

BiotechnologyGeneticsHealth CareMedicalTherapeutics

Epigenic Therapeutics is a drug development company that develops gene modulation therapies through the regulation of epigenetic mechanisms.

Shanghai, China
September 2025
$60.0M
Series B

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyMedicalPharmaceutical

Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.

Radnor, United States
September 2025
$287.5M
Post Ipo Equity

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyMedicalPharmaceuticalProduct ResearchTherapeutics

Minghui Pharmaceutical is a biopharmaceutical business that specializes in immunology and oncology medicines for unmet needs.

Shanghai, China
August 2025
$131.0M
Series Unknown

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife ScienceTherapeutics

Stratus Therapeutics develops off-the-shelf hematopoietic stem cell therapies to treat severe and life-threatening diseases.

Cambridge, United States
March 2025
$50.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth Care

ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs.

Copenhagen, Denmark
November 2024
$135.0M
Series B

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyTherapeutics

Pathalys is a clinical biopharmaceutical company that develops therapeutics that improve late-stage chronic kidney disease.

Raleigh, United States
August 2024
$105.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Chemomab is a clinical-stage biotech company focusing on the discovery and development of innovative therapeutics.

Tel Aviv, Israel
July 2024
$10.0M
Post Ipo Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyInformation TechnologyTechnical Support

Exsilio develops genomic therapeutics that introduce therapeutic genes into safe shelters within the DNA.

Boston, United States
June 2024
$82.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyMedicalPharmaceutical

Stemirna Therapeutics is a RNA technology based drug development company designed to maximize the potential of RNA science.

Beijing, China
May 2023
Series D

Founder Contacts

41,000+ verified contacts

Biotechnology

Laekna Therapeutics is a biotech company focusing on drug discovery and development.

Shanghai, China
May 2022
$61.0M
Series D

Founder Contacts

41,000+ verified contacts

AnalyticsBiotechnologyHealth CareMedicalMedical Device

MDClone offers a powerful, self-service data analytics environment enabling healthcare collaboration, research, and innovation.

Be'er Sheva, Israel
March 2022
$63.0M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyMedicalTherapeutics

HanBio Therapeutics is a biotechnology company committed to researching and developing next generation transformative medicines.

Shanghai, China
January 2022
$40.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyPharmaceutical

Zentera Therapeutics is a biopharmaceutical company.

Shanghai, China
August 2021
$75.0M
Series B

Founder Contacts

41,000+ verified contacts

Biotechnology

Zion Pharma is a drug discovery platform.

Shanghai, China
July 2021
$40.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyLife SciencePharmaceutical

Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing mutations.

Jerusalem, Israel
May 2021
$28.5M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyMedicalTherapeutics

Magenta Therapeutics is a new biotechnology company developing therapeutics that unlock the power of stem cell biology.

Cambridge, United States
May 2021
$86.4M
Post Ipo Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareInformation TechnologyPharmaceuticalTravel

Theseus Pharmaceuticals is a technology-based company.

New York, United States
April 2021
$100.0M
Series B

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth Diagnostics

Gemini Therapeutics focuses on genetically-defined dry age-related macular degeneration (AMD) and associated rare genetic diseases.

Cambridge, United States
February 2021
$95.0M
Post Ipo Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeuticsWellness

Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.

Philadelphia, United States
January 2021
$154.0M
Post Ipo Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyGenetics

LogicBio develops gene therapy vectors for previously incurable genetic and infectious diseases.

Foster City, United States
January 2021
Post Ipo Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

Emendo is a biotechnology company

New York, United States
December 2020
$250.0M
Corporate Round

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

SAGE Therapeutics develops and delivers novel medicines for most debilitating and disabling central nervous system disorders.

Cambridge, United States
November 2020
$650.0M
Post Ipo Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalPrecision MedicineTherapeutics

Turning Point Therapeutics is a pharmaceutical company that discovers and develops precision medicines for cancer and other diseases.

San Diego, United States
October 2020
$460.0M
Post Ipo Equity

Founder Contacts

41,000+ verified contacts

Biotechnology

BioNova Pharma biopharmaceutical company that develops treatments for cancer.

Shanghai, China
October 2020
$25.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyPharmaceutical

Zhaoke Ophthalmology Pharmaceutical is a Pharmaceutical platform.

Hong Kong, Hong Kong
October 2020
$145.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife SciencePharmaceutical

BioShin is a clinical stage biopharmaceutical company.

Shanghai, China
September 2020
$60.0M
Series A

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

InventisBio is a clinical-stage biotech company dedicated to the research and development of innovative small-molecule drugs.

Shanghai, China
September 2020
$147.0M
Series D

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

ReViral is a biotechnology company that develops and offers antiviral therapies for patients.

Stevenage, United Kingdom
August 2020
$44.0M
Series C

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CareMachine LearningMedical Device

MobileODT is an AI-based health-tech company that develops medical device technologies for cervical cancer screening.

Tel Aviv, Israel
August 2020
$4.0M
Series C

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedical Device

PMV Pharmaceuticals is a developer of p53-targeted small molecule drugs for the treatment of cancer.

Redwood City, United States
August 2020
$70.0M
Series D

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedical

Perfuse Therapeutics specializes in developing therapies for the treatment of eye disease.

San Francisco, United States
July 2020
$9.0M
Series A

Founder Contacts

41,000+ verified contacts

Big DataBiotechnologyHealth CareMedical

New Horizon Health is a bio-tech company focusing on early screening and genetic testing services for high-incidence cancer homes.

Hangzhou, China
July 2020
$30.0M
Series E

Founder Contacts

41,000+ verified contacts

BiotechnologyMedicalPharmaceuticalTherapeutics

Pionyr Immunotherapeutics is a developer of cancer immunotherapies designed to target the tumor microenvironment.

South San Francisco, United States
June 2020
$275.0M
Corporate Round

Founder Contacts

41,000+ verified contacts

BiotechnologyManufacturingMedical

MabPlex provides CDMO services in the development and manufacturing of biopharmaceuticals.

Fremont, United States
June 2020
$70.7M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyConsumer GoodsProduct Research

Norson Biotechnology produces edible probiotic powders, fermented lactic acid bacteria beverages, and other products.

Pingdu, China
June 2020
$70.7M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Protekt Therapeutics is a drug development company aiming to develop inhibitors of PKR for various diseases

Ness Ziona, Israel
November 2019
$4.1M
Series Unknown

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceutical

GrayBug is a biopharmaceutical company that develops transformative medicines for ocular diseases.

Redwood City, United States
August 2019
$80.0M
Series C

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth Care

Cleave Therapeutics is focused on protein homeostasis and stress pathways in cancer and neurodegeneration.

San Francisco, United States
August 2019
$12.0M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsTherapeutics

Prevail Therapeutics is a biotechnology company focused on developing novel gene therapies for patients with Parkinson’s disease.

New York, United States
March 2019
$50.0M
Series B

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyClinical TrialsMedical

resTORbio is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics.

Boston, United States
March 2019
$50.0M
Post Ipo Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedical DeviceOncologyPharmaceuticalTherapeutics

Peloton Therapeutics, a biotech company based in Dallas, is involved in discovering and developing novel drugs for cancer treatments.

Dallas, United States
February 2019
$150.0M
Series E

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Modis Therapeutics is bringing disease-modifying therapies to patients with rare genetic diseases.

Oakland, United States
October 2018
$30.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Bsense Bio Therapeutics develops small molecules for the treatment of sensory hyperexcitability related disorders.

Ness Ziona, Israel
October 2018
$405K
Seed

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeutics

KaNDy Therapeutics is a clinical-stage company focused on optimizing the potential of NT-814.

Stevenage, United Kingdom
August 2018
$32.6M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyMedicalTherapeutics

Therachon is a global biotechnology company focused on developing medicines for rare, genetic diseases

Basel, Switzerland
August 2018
$60.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedical Device

ARMO Biosciences is a biotechnology company that develops immune modulatory biologic therapeutics.

Redwood City, United States
January 2018
Series Unknown

Founder Contacts

41,000+ verified contacts

BiotechnologyClinical TrialsHealth Care

True North Therapeutics is a pioneering biotechnology company selectively inhibiting the Complement pathway for diseases.

South San Francisco, United States
January 2018
Series Unknown

Founder Contacts

41,000+ verified contacts

BioinformaticsBiotechnologyHealth CarePharmaceutical

Seragon Pharmaceuticals is a research-based company dedicated to improving human and animal health through innovative science.

Irvine, United States
October 2013
$30.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Arteaus Therapeutics is a biotechnology development company focused on creating new therapies to treat migraine.

Cambridge, United States
July 2012
$12.0M
Series Unknown

Founder Contacts

41,000+ verified contacts

BiotechnologyManufacturingPharmaceutical

Kalidex Pharmaceuticals develops quinolones to fight infections caused by multi-drug resistant organisms.

Menlo Park, United States
January 2012
$6.5M
Series Unknown

Founder Contacts

41,000+ verified contacts

Explore OrbiMed's Full Portfolio

View all companies funded by OrbiMed across every industry and funding stage.

View Full OrbiMed Portfolio